Literature DB >> 33177042

Covid-19: FDA authorises neutralising antibody bamlanivimab for non-admitted patients.

Elisabeth Mahase1.   

Abstract

Entities:  

Year:  2020        PMID： 33177042     DOI： 10.1136/bmj.m4362

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  24 in total

Review 1.  Viral targets for vaccines against COVID-19.

Authors:  Lianpan Dai; George F Gao
Journal:  Nat Rev Immunol       Date:  2020-12-18       Impact factor: 53.106

2.  An Atypical Case of COVID-19 Induced Pancytopenia, Rhabdomyolysis and Myocarditis.

Authors:  Olusayo Fadiran
Journal:  Cureus       Date:  2021-01-03

Review 3.  Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy.

Authors:  Elyse Latreille; Warren L Lee
Journal:  Viruses       Date:  2021-01-22       Impact factor: 5.048

4.  Mining of high throughput screening database reveals AP-1 and autophagy pathways as potential targets for COVID-19 therapeutics.

Authors:  Hu Zhu; Catherine Z Chen; Srilatha Sakamuru; Jinghua Zhao; Deborah K Ngan; Anton Simeonov; Mathew D Hall; Menghang Xia; Wei Zheng; Ruili Huang
Journal:  Sci Rep       Date:  2021-03-24       Impact factor: 4.996

Review 5.  Structure of SARS-CoV-2 Spike Glycoprotein for Therapeutic and Preventive Target.

Authors:  Jaewoo Hong; Hyunjhung Jhun; Yeo-Ok Choi; Afeisha S Taitt; Suyoung Bae; Youngmin Lee; Chang-Seon Song; Su Cheong Yeom; Soohyun Kim
Journal:  Immune Netw       Date:  2021-02-19       Impact factor: 6.303

Review 6.  Development and application of therapeutic antibodies against COVID-19.

Authors:  Lin Ning; Hamza B Abagna; Qianhu Jiang; Siqi Liu; Jian Huang
Journal:  Int J Biol Sci       Date:  2021-04-10       Impact factor: 6.580

Review 7.  Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 Therapies.

Authors:  Milo Gatti; Fabrizio De Ponti; Federico Pea
Journal:  CNS Drugs       Date:  2021-04-18       Impact factor: 5.749

Review 8.  HIV and COVID-19: Lessons From HIV and STI Harm Reduction Strategies.

Authors:  Ronnie M Gravett; Jeanne M Marrazzo
Journal:  Curr HIV/AIDS Rep       Date:  2021-06-08       Impact factor: 5.071

Review 9.  New Approaches and Repurposed Antiviral Drugs for the Treatment of the SARS-CoV-2 Infection.

Authors:  Bauso Luana Vittoria; Chiara Imbesi; Gasparo Irene; Gabriella Calì; Alessandra Bitto
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-25

Review 10.  Drug repurposing for COVID-19: Approaches, challenges and promising candidates.

Authors:  Yan Ling Ng; Cyrill Kafi Salim; Justin Jang Hann Chu
Journal:  Pharmacol Ther       Date:  2021-06-23       Impact factor: 12.310
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.